Physician profile
John C Harvey
NPI 1811952427
$1,189.56
in general payments reported to CMS, 2019-2025
21 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.88 · 2020: $17.38 · 2021: $73.13 · 2022: $150 · 2023: $182 · 2024: $197 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $192.30 | 2019-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $179.75 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $119.01 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $104.28 | 2025 | Capvaxive, Pifeltro, Zerbaxa |
| Lilly USA, LLC | $90.18 | 2023-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.05 | 2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.85 | 2021-2025 | Xifaxan |
| Viiv Healthcare Company | $47.28 | 2024-2025 | Cabenuva |
| Inspire Medical Systems, INC. | $44.46 | 2023-2024 | Inspire |
| Medtronic Vascular, INC. | $44.15 | 2019 | |
| Exact Sciences Corporation | $33.03 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $32.60 | 2024-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $30.89 | 2019-2024 | Arexvy |
| E.R. Squibb & Sons, L.L.C. | $21.64 | 2025 | Eliquis |
| Seqirus USA INC | $21.28 | 2025 | Fluad, Flucelvax |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $19.67 | 2025 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $19.60 | 2025 | Auvelity |
| Amgen INC. | $18.87 | 2025 | Evenity, Prolia |
| Radius Health, INC. | $18.40 | 2023 | Tymlos |
| Xeris Pharmaceuticals, INC. | $13.81 | 2023 | Gvoke Hypopen |
| Janssen Pharmaceuticals, INC | $11.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.